Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ERYP Erytech Pharma SA

0.00 (0.00%)
May 16 2024 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 0
Bid Price 0.77
Ask Price 0.9091
News -
Company Name Stock Ticker Symbol Market Type
Erytech Pharma SA ERYP NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.78 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.78 0.78
Trades Volume Avg Volume
0 0 -
Last Trade Time Type Quantity Stock Price Currency
- 0  0.78 USD

Erytech Pharma SA Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
0 60.75M - 1.33M -23.49M - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News Erytech Pharma

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No ERYP Message Board. Create One! See More Posts on ERYP Message Board See More Message Board Posts

ERYP Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months0.
6 Months0.
1 Year0.
3 Years0.
5 Years0.

Erytech Pharma SA is a clinical-stage biopharmaceutical company developing innovative therapies for severe forms of cancer and orphan diseases. Its ERYCAPS platform, uses a novel technology to encapsulate therapeutic drug substances inside erythrocytes, or red blood cells, or RBC. It is developing a pipeline of product candidates for patients with high unmet medical needs. Its lead product candidate eryaspase, also referred as GRASPA, targets the metabolism of cancer cells by depriving the cells of asparagine, an amino acid necessary for their survival and critical in maintaining the cells' rapid growth rate.

Your Recent History

Delayed Upgrade Clock